These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27658846)

  • 21. U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013.
    Hasin DS; Shmulewitz D; Cerdá M; Keyes KM; Olfson M; Sarvet AL; Wall MM
    Am J Psychiatry; 2020 Jul; 177(7):611-618. PubMed ID: 31964162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010.
    Alshaarawy O; Anthony JC
    Drug Alcohol Depend; 2015 Feb; 147():203-7. PubMed ID: 25529540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
    Wu LT; Zhu H; Mannelli P; Swartz MS
    Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Past-month cannabis use among U.S. individuals from 2002-2015: An age-period-cohort analysis.
    Chawla D; Yang YC; Desrosiers TA; Westreich DJ; Olshan AF; Daniels JL
    Drug Alcohol Depend; 2018 Dec; 193():177-182. PubMed ID: 30384326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use and cannabis use disorders among individuals with mental illness.
    Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
    Compr Psychiatry; 2013 Aug; 54(6):589-98. PubMed ID: 23375264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults: cross-sectional analyses from NHANES.
    Smith L; Sherratt F; Barnett Y; Cao C; Tully MA; Koyanagi A; Jacob L; Soysal P; López Sánchez GF; Shin JI; Yang L
    Public Health; 2021 Apr; 193():76-82. PubMed ID: 33743217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use and bone mineral density: NHANES 2007-2010.
    Bourne D; Plinke W; Hooker ER; Nielson CM
    Arch Osteoporos; 2017 Dec; 12(1):29. PubMed ID: 28286929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocaine's fall and marijuana's rise: questions and insights based on new estimates of consumption and expenditures in US drug markets.
    Caulkins JP; Kilmer B; Reuter PH; Midgette G
    Addiction; 2015 May; 110(5):728-36. PubMed ID: 25039446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Trends in Cannabis Use in Older Americans.
    Maxwell CJ; Jesdale BM; Lapane KL
    Ann Intern Med; 2021 Jan; 174(1):133-135. PubMed ID: 32866420
    [No Abstract]   [Full Text] [Related]  

  • 30. Marijuana buyers in the United States, 2010-2014.
    Azofeifa A; Sherman LJ; Mattson ME; Pacula RL
    Drug Alcohol Depend; 2018 Feb; 183():34-42. PubMed ID: 29223915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and correlates of marijuana use in Canada, 2012.
    Rotermann M; Langlois K
    Health Rep; 2015 Apr; 26(4):10-5. PubMed ID: 25875158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the production, consumption and export of cannabis: The Dutch case.
    van der Giessen M; van Ooyen-Houben MM; Moolenaar DE
    Int J Drug Policy; 2016 May; 31():104-12. PubMed ID: 27048853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.
    Lin LA; Ilgen MA; Jannausch M; Bohnert KM
    Addict Behav; 2016 Oct; 61():99-103. PubMed ID: 27262964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying HIV care enrollees at-risk for cannabis use disorder.
    Hartzler B; Carlini BH; Newville H; Crane HM; Eron JJ; Geng EH; Mathews WC; Mayer KH; Moore RD; Mugavero MJ; Napravnik S; Rodriguez B; Donovan DM
    AIDS Care; 2017 Jul; 29(7):846-850. PubMed ID: 28006972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method.
    Mojtabai R
    JAMA Psychiatry; 2022 Nov; 79(11):1074-1080. PubMed ID: 36129721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample.
    Kalla A; Krishnamoorthy PM; Gopalakrishnan A; Figueredo VM
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):480-484. PubMed ID: 29879084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012.
    Alshaarawy O; Elbaz HA
    J Hypertens; 2016 Aug; 34(8):1507-12. PubMed ID: 27270185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent rapid decrease in adolescents' perception that marijuana is harmful, but no concurrent increase in use.
    Sarvet AL; Wall MM; Keyes KM; Cerdá M; Schulenberg JE; O'Malley PM; Johnston LD; Hasin DS
    Drug Alcohol Depend; 2018 May; 186():68-74. PubMed ID: 29550624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in cannabis use among immigrants in the United States, 2002-2017: Evidence from two national surveys.
    Salas-Wright CP; John R; Vaughn MG; Eschmann R; Cohen M; AbiNader M; Delva J
    Addict Behav; 2019 Dec; 99():106029. PubMed ID: 31593886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sizing the cannabis market: a demand-side and user-specific approach in seven European countries.
    van Laar M; Frijns T; Trautmann F; Lombi L
    Curr Drug Abuse Rev; 2013 Jun; 6(2):152-64. PubMed ID: 24308518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.